Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Altus Pharmaceuticals, Inc.
Pharmaceutical firm raises $51M in series C financing
June 26th, 2004
Altus Pharmaceuticals, Inc., formerly Altus Biologics, Inc., a company developing novel therapies to treat chronic gastrointestinal and metabolic diseases, announced that it has secured $51 million in a Series C financing led by Warburg Pincus, a healthcare private equity investor. In conjunction with the financing, Stewart Hen and Jonathan Leff, both managing directors at Warburg Pincus, have joined Altus' board of directors. Altus expects to use the proceeds from the financing to advance its lead product for pancreatic insufficiency through phase II clinical trials and to advance and expand its robust pipeline of products to treat patients with...
Source: Law & Health Weekly (2004-06-26)
|
